Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma (HCC); Unresectable Hepatocellular Carcinoma Interventions: Drug: Yttrium-90; Device: Selective Internal Radiation Therapy; Radiation: Stereotactic Body Radiation Therapy; Diagnostic Test: PET/CT; Device: Therasphere Sponsors: University of Michigan Rogel Cancer Center; Department of Health and Human Services Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brachytherapy | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Radiation Therapy | Research